These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 19354203

  • 61. Automated molecular library generation of proteic fragments by virtual proteolysis for molecular modelling studies.
    Librando V, Gullotto D, Minniti Z.
    In Silico Biol; 2006; 6(5):449-57. PubMed ID: 17274772
    [Abstract] [Full Text] [Related]

  • 62. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM, Bernardo PH, Chai CL, Tong JC.
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [Abstract] [Full Text] [Related]

  • 63. Ligand mapping on protein surfaces by the 3D-RISM theory: toward computational fragment-based drug design.
    Imai T, Oda K, Kovalenko A, Hirata F, Kidera A.
    J Am Chem Soc; 2009 Sep 02; 131(34):12430-40. PubMed ID: 19655800
    [Abstract] [Full Text] [Related]

  • 64. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M, Proschak E, Schüller A, Schneider G.
    Chem Biol Drug Des; 2008 Jul 02; 72(1):16-26. PubMed ID: 18564216
    [Abstract] [Full Text] [Related]

  • 65. Deconstructing fragment-based inhibitor discovery.
    Babaoglu K, Shoichet BK.
    Nat Chem Biol; 2006 Dec 02; 2(12):720-3. PubMed ID: 17072304
    [Abstract] [Full Text] [Related]

  • 66. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
    Rastelli G, Degliesposti G, Del Rio A, Sgobba M.
    Chem Biol Drug Des; 2009 Mar 02; 73(3):283-6. PubMed ID: 19207463
    [Abstract] [Full Text] [Related]

  • 67. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
    Golub AG, Yakovenko OY, Bdzhola VG, Sapelkin VM, Zien P, Yarmoluk SM.
    J Med Chem; 2006 Nov 02; 49(22):6443-50. PubMed ID: 17064064
    [Abstract] [Full Text] [Related]

  • 68. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M, Kanamori E, Nakamura H, Fukunishi Y.
    J Chem Inf Model; 2011 Sep 26; 51(9):2398-407. PubMed ID: 21848279
    [Abstract] [Full Text] [Related]

  • 69. The challenge of predicting drug toxicity in silico.
    Vedani A, Dobler M, Lill MA.
    Basic Clin Pharmacol Toxicol; 2006 Sep 26; 99(3):195-208. PubMed ID: 16930291
    [Abstract] [Full Text] [Related]

  • 70. Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening.
    Kovac A, Konc J, Vehar B, Bostock JM, Chopra I, Janezic D, Gobec S.
    J Med Chem; 2008 Dec 11; 51(23):7442-8. PubMed ID: 19053785
    [Abstract] [Full Text] [Related]

  • 71. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
    Cozza G, Gianoncelli A, Montopoli M, Caparrotta L, Venerando A, Meggio F, Pinna LA, Zagotto G, Moro S.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5672-5. PubMed ID: 18799313
    [Abstract] [Full Text] [Related]

  • 72. SVM model for virtual screening of Lck inhibitors.
    Liew CY, Ma XH, Liu X, Yap CW.
    J Chem Inf Model; 2009 Apr 15; 49(4):877-85. PubMed ID: 19267483
    [Abstract] [Full Text] [Related]

  • 73. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T, Chan NS, Brass S, Sotriffer CA, Klebe G, Diederich WE.
    ChemMedChem; 2008 Sep 15; 3(9):1323-36. PubMed ID: 18752222
    [Abstract] [Full Text] [Related]

  • 74. Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
    Ekonomiuk D, Su XC, Ozawa K, Bodenreider C, Lim SP, Otting G, Huang D, Caflisch A.
    J Med Chem; 2009 Aug 13; 52(15):4860-8. PubMed ID: 19572550
    [Abstract] [Full Text] [Related]

  • 75. Fragment-based drug design: combining philosophy with technology.
    Bartoli S, Fincham CI, Fattori D.
    Curr Opin Drug Discov Devel; 2007 Jul 13; 10(4):422-9. PubMed ID: 17659483
    [Abstract] [Full Text] [Related]

  • 76. NMR fragment screening: tackling protein-protein interaction targets.
    Schade M, Oschkinat H.
    Curr Opin Drug Discov Devel; 2005 May 13; 8(3):365-73. PubMed ID: 15892252
    [Abstract] [Full Text] [Related]

  • 77. Classification of chemical compounds by protein-compound docking for use in designing a focused library.
    Fukunishi Y, Mikami Y, Takedomi K, Yamanouchi M, Shima H, Nakamura H.
    J Med Chem; 2006 Jan 26; 49(2):523-33. PubMed ID: 16420039
    [Abstract] [Full Text] [Related]

  • 78. Efficient discovery of inhibitory ligands for diverse targets from a small combinatorial chemical library of chimeric molecules.
    Thorpe DS, Edith Chan AW, Binnie A, Chen LC, Robinson A, Spoonamore J, Rodwell D, Wade S, Wilson S, Ackerman-Berrier M, Yeoman H, Walle S, Wu Q, Wertman KF.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):62-5. PubMed ID: 10581165
    [Abstract] [Full Text] [Related]

  • 79. In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.
    Fujimoto T, Matsushita Y, Gouda H, Yamaotsu N, Hirono S.
    Bioorg Med Chem Lett; 2008 May 01; 18(9):2771-5. PubMed ID: 18434150
    [Abstract] [Full Text] [Related]

  • 80. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL.
    Methods Enzymol; 2011 May 01; 493():137-55. PubMed ID: 21371590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.